ISIN | LU0515381530 |
---|---|
Valor Number | 11459409 |
Bloomberg Global ID | BBG001746GN4 |
Fund Name | CT (Lux) European Growth & Income A EUR |
Fund Provider |
Columbia Threadneedle Investments
Web: www.columbiathreadneedle.com Phone: +352 464 0107 460 E-Mail: Lux-CTenquiries@statestreet.com |
Fund Provider | Columbia Threadneedle Investments |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Banque Cantonale de Genève Genève 2 Phone: +41 22 317 27 27 |
Asset Class | Bonds |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Portfolio is to achieve long-term capital appreciation and an enhanced level of income by investing in companies listed on one of the European States Stock Exchanges or a regulated market. |
Peculiarities |
Current Price * | 28.12 EUR | 16.04.2025 |
---|---|---|
Previous Price * | 28.31 EUR | 15.04.2025 |
52 Week High * | 31.41 EUR | 26.02.2025 |
52 Week Low * | 25.92 EUR | 09.04.2025 |
NAV * | 28.12 EUR | 16.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 58,481,032 | |
Unit/Share Assets *** | 6,343,969 | |
Trading Information SIX |
YTD Performance | -2.80% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -4.15% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -8.19% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -4.90% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -2.97% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +3.65% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +19.10% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +25.26% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +78.09% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 3.78% | |
---|---|---|
Intesa Sanpaolo | 3.36% | |
Roche Holding AG | 3.36% | |
Novo Nordisk AS Class B | 3.22% | |
M&G PLC Ordinary Shares | 2.88% | |
ASML Holding NV | 2.84% | |
Sanofi SA | 2.67% | |
Siemens AG | 2.58% | |
Bank of Ireland Group PLC | 2.53% | |
Phoenix Group Holdings PLC | 2.53% | |
Last data update | 28.02.2025 |
TER *** | 1.84% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.00% |
Ongoing Charges *** | 1.70% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |